129 related articles for article (PubMed ID: 34042273)
1. Reduced serum miR-202 may promote the progression of Alzheimer's disease patients via targeting amyloid precursor protein.
Dong LH; Sun L; Zhang WJ; Wang XY; Li JM
Kaohsiung J Med Sci; 2021 Aug; 37(8):730-738. PubMed ID: 34042273
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
3. Relationship between single nucleotide polymorphisms in the 3'UTR of amyloid precursor protein and risk of Alzheimer's disease and its mechanism.
Zhou Q; Luo L; Wang X; Li X
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30914454
[No Abstract] [Full Text] [Related]
4. Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-β induced neurotoxicity by targeting PTEN.
Cao F; Liu Z; Sun G
Exp Gerontol; 2020 Feb; 130():110814. PubMed ID: 31857133
[TBL] [Abstract][Full Text] [Related]
5. Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.
Kumar S; Reddy AP; Yin X; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2428-2440. PubMed ID: 31181293
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
7. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W
Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113
[TBL] [Abstract][Full Text] [Related]
8. An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease.
Wang J; Chen C; Zhang Y
J Clin Lab Anal; 2020 Jan; 34(1):e23006. PubMed ID: 31420923
[TBL] [Abstract][Full Text] [Related]
9. MiR-16 regulates cell death in Alzheimer's disease by targeting amyloid precursor protein.
Zhang B; Chen CF; Wang AH; Lin QF
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4020-7. PubMed ID: 26592823
[TBL] [Abstract][Full Text] [Related]
10. Circular HDAC9/microRNA-138/Sirtuin-1 Pathway Mediates Synaptic and Amyloid Precursor Protein Processing Deficits in Alzheimer's Disease.
Lu Y; Tan L; Wang X
Neurosci Bull; 2019 Oct; 35(5):877-888. PubMed ID: 30887246
[TBL] [Abstract][Full Text] [Related]
11. MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14.
Ji Q; Wang X; Cai J; Du X; Sun H; Zhang N
Curr Neurovasc Res; 2019; 16(5):473-480. PubMed ID: 31713484
[TBL] [Abstract][Full Text] [Related]
12. miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer's disease.
Zhang QS; Liu W; Lu GX
J Biosci; 2017 Sep; 42(3):397-404. PubMed ID: 29358553
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2.
Liang C; Zhu H; Xu Y; Huang L; Ma C; Deng W; Liu Y; Qin C
Brain Res; 2012 May; 1455():103-13. PubMed ID: 22510281
[TBL] [Abstract][Full Text] [Related]
14. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
Wang D; Fei Z; Luo S; Wang H
Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.
Liu Y; Zhang Y; Liu P; Bai H; Li X; Xiao J; Yuan Q; Geng S; Yin H; Zhang H; Wang Z; Li J; Wang S; Wang Y
Eur J Pharmacol; 2019 Jan; 843():134-144. PubMed ID: 30412727
[TBL] [Abstract][Full Text] [Related]
16. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
17. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
[TBL] [Abstract][Full Text] [Related]
18. APP processing and metabolism in corneal fibroblasts and epithelium as a potential biomarker for Alzheimer's disease.
Choi SI; Lee B; Woo JH; Jeong JB; Jun I; Kim EK
Exp Eye Res; 2019 May; 182():167-174. PubMed ID: 30930125
[TBL] [Abstract][Full Text] [Related]
19. miR-15b reduces amyloid-β accumulation in SH-SY5Y cell line through targetting NF-κB signaling and BACE1.
Li J; Wang H
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29961672
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease.
Liu CG; Song J; Zhang YQ; Wang PC
Mol Med Rep; 2014 Nov; 10(5):2395-400. PubMed ID: 25119742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
